Delivery Order SPE2DB22D1017-SPE2DB25FE9FE

Award Date 11/15/24
Potential Completion Date 11/18/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FE9FE
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp is a delivery order for the pharmaceutical product Lantus Solostar 100 Unit/mL 3mL. The $1,231.33 award was made by the Defense Logistics Agency (DLA), a Department of Defense agency, on November 15, 2024, with an ultimate completion date of November 18, 2024. The contract is an Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999, which serves as a primary vehicle for the DLA to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this delivery order, which provides the Lantus Solostar insulin product to DLA to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 2/14/25, 9:33 AM